AstraZeneca diabetes drug granted fast track status for heart failure treatment

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Sep 16, 2019 at 9:52 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,746
    Likes Received:
    3
    via AstraZeneca's diabetes drug, Farxiga, has been granted fast track designation by U.S. regulators for the treatment of heart failure, boosting prospects of wider use of the drug and putting it ahead of rivals.

    article source